Emerging MS technologies may offer biomarker discovery and validation opportunities not afforded by conventional means due to its ability to handle the complexities associated with the proteome. While MS techniques are relatively early in development in the neurosciences space, the potential applications to TBI and neurocritical care are likely to accelerate in the coming decade.
Keyphrases
- mass spectrometry
- traumatic brain injury
- small molecule
- liquid chromatography
- high throughput
- gas chromatography
- high performance liquid chromatography
- multiple sclerosis
- capillary electrophoresis
- ms ms
- high resolution
- healthcare
- severe traumatic brain injury
- quality improvement
- palliative care
- pain management
- affordable care act
- chronic pain
- health insurance